臨床試驗

Pharmacologic Augmentation of TMS for Depression With D-serine

NCT：NCT06876129 · RECRUITING

NCT IDNCT06876129

狀態RECRUITING

開始日期2025-04-01

完成時間2027-04-01

SponsorMclean Hospital (OTHER)

First posted2025-03-14

Last updated2026-05-15

簡要摘要

The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce greater clinical outcomes than iTBS with placebo and 18-Hz with placebo.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。